 |
|
 |
 |
|
 |
The VAP Lipid Panel |
 |
|
 |
 |
|
 |
|
 |
|
 |
 |
|
|
The VAP Lipid Panel
- Is the first comprehensive lipid profile to comply with guidelines (NCEP/ATP III, AACE, and ADA/ACC)
- Guidelines recommend a comprehensive approach to risk stratification1-3
- Is the test of choice for accurate, global cardiometabolic risk stratification and management
- Provides comprehensive lipid analysis
- Simultaneously and accurately measures cholesterol concentrations of all 5 lipoprotein classes and their subclasses in a non-fasting patient4
- Clarifies risk and drives a personalized treatment approach based on 3 categories of residual cardiometabolic risk
- Cholesterol - Directly measures LDL and HDL, providing accurate results in a non-fasting patient. Also measures subclasses including apoB, which reflects atherogenic load.
- Triglycerides - Identifies triglyceride-rich disorders, including non-HDL, even in patients with seemingly normal triglyceride levels.
- Heredity - Identifies Lp(a), a hereditary marker of risk.
|
References
- Jellinger PS, Dickey RA, Ganda OP, et al; AACE Lipid Guidelines Committee. AACE medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis. Endocr Pract. 2000;6(2):162-213.
- Grundy SM, Cleeman JI, Merz CN, et al; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227-239.
- Brunzell JD, Davidson M, Furberg CD, et al; American Diabetes Association; American College of Cardiology Foundation. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care. 2008;31(4):811-822.
- Analytical performance of the cholesterol profi le measurement by Vertical Auto Profi le [VAP]: analysis of NCEP III guidelines lipid analytes. Atherotech Web site. http://www.atherotech.com/images/vapliterature/pdfs/vapaccuracywhitepaper_20110831.pdf. Published 2011. Accessed May 10, 2012.
|
|
"Advanced lipid profiles help clinical researchers focus efforts on discovering who is truly at risk for cardiovascular disease and how we can better manage this risk."
- Michael H. Davidson, M.D., F.A.C.C., F.A.C.P., Clinical Professor at the University of Chicago Pritzker School of Medicine, Director of Preventive Cardiology and Associate Vice Chairman for Continuing Medical Education at the University of Chicago Pritzker School of Medicine |
|
|